Discontinuing Inappropriate Medication in Nursing Home Residents (the DIM NHR study): a cluster randomized controlled trial.
- Conditions
- polyfarmaciepolypharmacyuse of multiple drugs at the same time
- Registration Number
- NL-OMON40684
- Lead Sponsor
- Rijksuniversiteit Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 420
Nursing Home Ward Level:;• Long stay ward.
• Capability and commitment to perform a multidisciplinary multistep medication review in the way as outlined in paragraph 4.1 Treatment of the study protocol. ;Nursing Home Residents Level:;• A life expectancy of >4 weeks as judged by the treating elderly care physician.
• IC provided by patients themselves or provided by a legal representative of incapacitated patients.
Nursing Home Ward Level:;• Short stay, revalidation or observation wards as including these will inflate the rate of patients who are lost to follow-up.
• Specialized ward where patients with an atypical etiology e.g. lifespan psychiatric illness, alcohol dementia, AIDS, and mental disability are cared for.
• Elderly care physicians who have recently received or who are to receive recertification at short notice with regard to systematic medication review methodology.
• Participation in other studies aimed at improving the quality of drug prescription (in the past 12 months).;Nursing Home Residents Level:;• Refusal of treatment with medicines.
• Having received a multidisciplinary systematic medication review in the past 6 months.
• Being terminally ill and having a life expectancy <= 4 weeks as judged by the treating elderly care physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The difference in the proportion of residents for whom inappropriate medication<br /><br>will be discontinued (intervention group versus control group).</p><br>
- Secondary Outcome Measures
Name Time Method <p>Underprescribing; Exposure to anticholinergic and sedative medication; side<br /><br>effecs of medication; neuropsychiatric symptoms; cognitive function; quality of<br /><br>life; hospital admissions; mortality risk.</p><br>